Pfizer Inc.

PFE

US7170811035

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 10:42:11 13/03/2026 pm IST			5-day change	1st Jan Change
26.70 ^USD	-0.58%		-1.10%	+7.44%

04:34pm	Health Rounds: Eliquis proves safer than Xarelto for patients with deep blood clots	RE
04:33pm	GSK gets US FDA approval for expanded use of RSV vaccine	RE

Health Care Up Amid Defensive Bias -- Health Care Roundup

Published on 01/30/2026 at 04:11 am IST

Dow Jones

PFIZER INC.

-0.58%

ROCHE HOLDING AG

+0.79%

UNITEDHEALTH GROUP INC.

+1.29%

Health-care companies rose as traders rotated into the defensive sector from high-risk niches such as artificial intelligence.

Some health insurers, such as UnitedHealth, recouped losses incurred after the surprisingly meager increase in proposed Medicare reimbursement rates.

Swiss drug giant Roche said it expects sales and core earnings per share to grow at constant currencies this year, partly due to the strength of its drug pipeline.

Big Pharma companies such as Pfizer and Merck rose ahead of their earnings next week.

Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

01-29-26 1740ET

Stocks mentioned in the article

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
PFIZER INC.	26.70USD	-0.58%	-1.10%	15TCr
ROCHE HOLDING AG	320.70CHF	+0.79%	-6.01%	32TCr
UNITEDHEALTH GROUP INC.	280.62USD	+1.29%	-1.87%	25TCr

Latest news about Pfizer Inc.

04:34pm	Health Rounds: Eliquis proves safer than Xarelto for patients with deep blood clots	RE
04:33pm	GSK gets US FDA approval for expanded use of RSV vaccine	RE
10/03	PFIZER INC : UBS is Neutral	ZD
10/03	BioNTech founders plan exit to set up new venture, shares slump	RE
10/03	Pfizer Inc. Reports Positive Phase 2 Results for tilrekimig (PF-07275315) in Atopic Dermatitis	CI
09/03	Global drugmakers rush to boost US presence as tariff threat looms	RE
09/03	Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study -- Update	DJ
09/03	Global markets live: Live Nation, Eli Lilly, Amazon, Microsoft, ABB…
09/03	Pfizer to Advance Eczema Treatment to Phase 3 After Phase 2 Study Hits Goal	DJ
09/03	Pfizer Says Phase 2 Study of Tilrekimig Shows Reduction in Severity of Atopic Dermatitis	MT
09/03	Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study	RE
09/03	Pfizer's phase 2 study of trispecific antibody positive in moderate to severe atopic dermatitis	RE
09/03	Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study	DJ
09/03	Roche shares drop as oral breast cancer drug combination fails key trial	RE
09/03	Roche Breast-Cancer Treatment Falls Short of Primary Goal in Late-Stage Study	DJ

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (47.4%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (26.2%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (24.5%); - other (1.9%). The United States accounts for 60.8% of net sales.

Employees

75,000

Sector

Pharmaceuticals

More about the company